In clinical research, ISF stands for Investigator Site File, a collection of essential documents maintained at each research site to demonstrate that the trial is being conducted properly. It tells the complete story of a study from start to finish, covering everything from regulatory approvals to participant consent records to proof that staff are qualified. Think of it as the paper trail that proves a clinical trial site followed the rules.
What the ISF Contains
The ISF is essentially a comprehensive binder (or digital folder) holding every document that regulators, auditors, or sponsors might need to verify a site’s compliance. While the exact contents vary by study type, a typical ISF includes:
- Investigator credentials: The principal investigator’s CV, clinical license, and for studies involving an investigational new drug (IND), a signed FDA Form 1572
- Protocol documents: The current protocol, any amendments, and signed protocol signature pages
- Ethics approvals: IRB approval letters for the protocol, consent forms, recruitment advertisements, and annual renewals
- Informed consent forms: IRB-approved versions of every consent document used with participants
- Staff documentation: CVs for sub-investigators, financial disclosure statements, and proof of human subjects protection training for all research staff
- Lab documentation: Normal value ranges for any medical or laboratory tests, plus certifications for labs performing those tests
- Investigational product records: Shipping logs, accountability records, certificates of analysis, storage instructions, and (if applicable) instructions for breaking the blind
- Investigator’s Brochure: The reference document summarizing what’s known about the study drug or device
- Relevant correspondence: Any significant communication with the IRB or regulatory bodies
Some studies require additional documents, such as a DEA license if controlled substances are involved, or evidence that the protocol was submitted to the FDA.
Why the ISF Matters
The ISF exists to demonstrate three things: that the site followed regulatory requirements, that study data has integrity, and that the trial complied with Good Clinical Practice (GCP) standards. When an auditor or inspector visits a research site, the ISF is typically the first thing they review. A well-maintained file shows that consent was properly obtained, that qualified people ran the study, and that the investigational product was handled correctly.
A disorganized or incomplete ISF, on the other hand, raises immediate red flags. Missing documents can trigger findings during audits, delay study closeout, or in serious cases lead to regulatory action against the site or investigator.
Who Is Responsible for It
The principal investigator (PI) holds ultimate responsibility for the ISF. By signing FDA Form 1572, the PI guarantees to personally conduct or directly supervise the study, and that includes keeping regulatory binders up to date. While day-to-day management of the file is often delegated to a clinical research coordinator or other study staff, the PI is legally accountable for noncompliance or misconduct by anyone working on the study.
This is a point that trips up some investigators. Delegating tasks is expected and normal, but delegation doesn’t transfer responsibility. If a coordinator forgets to file an updated IRB approval letter, that gap falls on the PI during an audit.
How the ISF Differs From the TMF
If you’re new to clinical research, you’ll encounter two similar-sounding terms: the ISF and the Trial Master File (TMF). They serve related but distinct purposes.
The TMF belongs to the sponsor or contract research organization (CRO). It focuses on oversight, compliance, and governance across the entire trial, often spanning dozens of sites in multiple countries. The ISF belongs to the individual site and its principal investigator. Its focus is narrower: execution, ethics, and participant-level data at that specific location. The TMF is the global view of the trial. The ISF is the frontline evidence that one site did its job correctly.
There’s natural overlap between the two. Both contain copies of the protocol, investigator brochure, and regulatory correspondence. But the ISF also holds site-specific documents like local lab certifications and individual staff training records that wouldn’t appear in the sponsor’s TMF.
Paper vs. Electronic ISF
Traditionally, the ISF lived in physical binders stored at the research site. Many sites have now transitioned to electronic systems, commonly called an eISF. These digital platforms offer clear advantages: documents are easier to search, share with monitors remotely, and back up securely. They also reduce the risk of misfiling or losing critical paperwork.
Electronic systems must meet specific regulatory requirements, though. The FDA’s 21 CFR Part 11 sets the criteria for when electronic records and electronic signatures can legally replace paper. Key requirements include limiting system access to authorized individuals, using operational and authority checks, maintaining audit trails, and establishing written policies that hold people accountable for actions taken under their electronic signatures. Staff who use, develop, or maintain these systems need appropriate training and experience.
Records stored electronically must remain secure and retrievable throughout the entire retention period, just as paper records would be. An eISF that doesn’t meet these standards could be challenged during an inspection.
How Long to Keep the ISF
The ISF doesn’t disappear when a study ends. Federal regulations require retention for specific periods after trial completion. Under HHS regulations, clinical research records must be kept for at least 3 years after the research is completed. FDA regulations add a separate requirement: records must be retained for at least 2 years after a drug is approved or disapproved, the IND is withdrawn, or the study is discontinued.
In practice, the longer of these two timelines applies, and sponsors often impose even longer retention periods in their contracts. For trials supporting a drug that takes years to reach approval, the ISF may need to be stored for a decade or more. Sites should confirm the specific retention requirements with the sponsor before archiving or destroying any documents.